Alumis, Inc. (ALMS)
6.85
-0.36
(-4.99%)
USD |
NASDAQ |
Oct 02, 16:00
6.845
0.00 (0.00%)
After-Hours: 20:00
Alumis Profit Margin (Quarterly) : -8.56K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.56K% |
| March 31, 2026 | -5.34K% |
| December 31, 2025 | -4.82K% |
| Date | Value |
|---|---|
| September 30, 2025 | -5.36K% |
| June 30, 2025 | |
| March 31, 2025 | -569.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.86% |
| Corcept Therapeutics, Inc. | 16.45% |
| Aclaris Therapeutics, Inc. | -1.32K% |
| BioAge Labs, Inc. | -1.06K% |
| ANI Pharmaceuticals, Inc. | 8.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -100.2% |
| Return on Assets | -79.89% |
| Return on Invested Capital | -92.37% |
| Gross Profit Margin (Quarterly) | 47.41% |
| Operating Margin (Quarterly) | -6.44K% |
| Return on Net Operating Assets | -497.6% |